NCT03499795 2023-07-14VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2Inovio PharmaceuticalsPhase 2 Completed23 enrolled 19 charts
NCT02399813 2023-03-20A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal CanalAdvaxis, Inc.Phase 2 Completed36 enrolled 11 charts
NCT01651949 2018-11-27Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)Merck Sharp & Dohme LLCPhase 3 Completed2,520 enrolled 13 charts
NCT01236053 2017-07-06Cancer in Patients With Gabapentin (GPRD)GlaxoSmithKlineCompleted2,323,608 enrolled 86 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts